Local pulmonary opioid network in patients with lung cancer: A putative modulator of respiratory function

Pharmacological Reports

Volumn 62, Issue 1, 2010, Pages 139-149

  Krajnik, Małgorzata ^a   Schäfer, Michael ^b   Sobański, Piotr ^a   Kowalewski, Janusz ^a   Bloch Bogusławska, Elzbieta ^a   Zylicz, Zbigniew ^c   Mousa, Shaaban A ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Dove House Hospice   (United Kingdom)

Author keywords

Carboxypeptidase; Convertase; Inhalation; Opioid; Proopiomelanocortin

Indexed keywords

BETA ENDORPHIN; CARBOXYPEPTIDASE H; MORPHINE; MU OPIATE RECEPTOR; OPIATE RECEPTOR; PROOPIOMELANOCORTIN; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE 2;

ARTICLE; BRONCHUS MUCOSA; CANCER CELL; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG ALVEOLUS MACROPHAGE; LUNG CANCER; LUNG FUNCTION; MALE; NERVE ENDING; NEUROSECRETORY CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SENSORY NERVE; TREATMENT RESPONSE;

EID: 77950817218     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70251-6     Document Type: Article

References (41)

1. Adriaensen D, Brouns I, Pintelon I, De Proost I, Timmermans JP: Evidence for a role of neuroepithelial bodies as complex airway sensors: comparison with smooth muscle-associated airway receptors. J Appl Physiol, 2006,101,960-970.
2. Ballard ST, Spadafora D: Fluid secretion by submucosal glands of the tracheobronchial airways. Respir Physiol Neurobiol, 2007, 159, 271-277.
3. Belvisi MG, Stretton CD, Verleden GM, Ledingham SJ, Yacoub MH, Barnes PJ: Inhibition of cholinergic neurotransmission in human airways by opioids. J Appl Physiol, 1992, 72, 1096-1100.
4. Benjannet S, Rondeau N, Day R, Chrétien M, Seidah NG: PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc Natl Acad Sci USA, 1991, 88, 3564-3568.
5. Bhargava HN, Villar VM, Cortijo J, Morcillo EJ: Binding of [H][D-Ala, MePhe, Gly-ol] enkephalin, [H][D-Pen, D-Pen]enkephalin, and [H]U-69,593 to airway and pulmonary tissues of normal and sensitized rats. Peptides, 1997, 18, 1603-1608.
6. Bidlack JM, Khimich M, Parkhill AL, Sumagin S, Sun B, Tipton CM: Opioid receptors and signaling on cells from the immune system. J Neuroimmune Pharmacol, 2006,1,260-269.
7. Black M, Carey FA, Farquharson MA, Murray GD, McNicol AM: Expression of the pro-opiomelanocortin gene in lung neuroendocrine tumours: in situ hybridization and immunohistochemical studies. J Pathol, 1993, 169,329-334.
8. Bruera E, Sala R, Spruyt O, Palmer JL, Zhang T, Willey J: Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study. J Pain Symptom Manage, 2005, 29, 613-618.
9. Cabot PJ, Dodd PR, Cramond T, Smith MT: Characterization of non-conventional opioid binding sites in rat and human lung. Eur J Pharmacol, 1994, 268, 247-255.
10. Cadet P, Rasmussen M, Zhu W, Tonnesen E, Mantione KJ, Stefano GB: Endogenous morphinergic signaling and tumor growth. Front Biosci, 2004, 9, 3176-3186.
11. Coyne PJ, Viswanathan R, Smith TJ: Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea. J Pain Symptom Manage, 2002, 23, 157-160.
12. Cutz E, Perrin DG, Pan J, Haas EA, Krous HF: Pulmonary neuroendocrine cells and neuroepithelial bodies in sudden infant death syndrome: potential markers of airway chemoreceptor dysfunction. Pediatr Dev Pathol, 2007,10,106-116.
13. Graff GR, Stark JM, Grueber R: Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient. Respiration, 2004, 71, 646-649.
14. Haworth R, Woodfine J, McCawley S, Pilling AM, Lewis DJ, Williams TC: Pulmonary neuroendocrine cell hyperplasia: identification, diagnostic criteria and incidence in untreated ageing rats of different strains. Toxicol Pathol, 2007, 35, 735-740.
15. Horii S, Tamaoki J, Kanemura T, Yamawaki I, Takizawa T: Effects of beta-endorphin and dynorphin A on cholinergic neurotransmission in canine airway smooth muscle. Eur J Pharmacol, 1990, 182, 497-502.
16. Ishihara H, Shimura S, Satoh M, Masuda T, Nonaka H, Kase H, Sasaki T et al.: Muscarinic receptor subtypes in feline tracheal submucosal gland secretion. Am J Physiol, 1992,262, L223-L228.
17. James DE, Nijkamp FP: Neuroendocrine and immune interactions with airway macrophages. Inflamm Res, 2000, 49,254-265.
18. Jennings AL, Davies AN, Higgins JP, Broadley K. Opioids for the palliation of breathlessness in terminal illness. Cochrane Database Syst Rev, 2001, CD002066.
19. Krajnik M, Podolec Z, Zylicz Z, Jassem E: Air humidity may influence the aerosol distribution of normal saline administered by closed or vented nebulizers operated continuously or dosimetrically. J Aerosol Med Pulm Drug Deliv, 2009, 22, 29-34.
20. Loh YP, Maldonado A, Zhang C, Tam WH, Cawley N: Mechanism of sorting proopiomelanocortin and proenkephalin to the regulated secretory pathway of neuroendocrine cells. Ann NY Acad Sci, 2002, 97, 416-425.
21. Mahler DA, Murray JA, Waterman LA, Ward J, Kraemer WJ, Zhang X, Baird JC: Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD. Eur Respir J, 2009, 33, 771-777.
22. Maneckjee R, Minna JD: Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc Natl Acad Sci USA, 1990, 87, 3294-3298.
23. Mazzocato C, Buclin T, Rapin CH: The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Ann Oncol, 1999, 10, 1511-1514.
24. Mechanick JI, Levin N, Roberts JL, Autelitano DJ: Proopiomelanocortin gene expression in a distinct population of rat spleen and lung leukocytes. Endocrinology, 1992,131,518-525.
25. Mousa SA, Straub RH, Schäfer M, Stein C: -Endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis. Ann Rheum Dis, 2007, 66,871-879.
26. Mousa SA, Cheppudira BP, Shaqura M, Fischer O, Hofmann J, Hellweg R, Schäfer M: Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain, 2007, 130, 502-513.
27. Mousa SA, Shakibaei M, Sitte N, Schäfer M, Stein C: Subcellular pathways of -endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology, 2004, 145, 1331-1341.
28. Murgo AJ: Inhibition of B16-BL6 melanoma growth in mice by methionine-enkephalin. J Natl CancerInst,1985, 75,341-344.
29. Nagaki M, Ishihara H, Shimura S, Sasaki T, Takishima T, Shirato K: Tachykinins induce a [Ca] rise in the acinar cells of feline tracheal submucosal gland. Respir Physiol, 1994, 98, 111-120.
30. Plotnikoff NP, Miller GC: Enkephalins as immunomodulators. Int J Immunopharmacol, 1983, 5, 437-441.
31. Ramnarine SI, Liu YC, Rogers DF: Neuroregulation of mucus secretion by opioid receptors and K and BK channels in ferret trachea in vitro. Br J Pharmacol, 1998, 123,1631-1638.
32. Roth KA, Barchas JD: Small cell carcinoma cell lines contain opioid peptides and receptors. Cancer, 1986, 57, 769-773.
33. Scholar EM, Violi L, Hexum TD: The antimetastatic activity of enkephalin-like peptides. Cancer Lett, 1987, 35, 133-138.
34. Shimura S: Signal transduction of mucous secretion by bronchial gland cells. Cell Signal, 2000, 12, 271-277.
35. Smith AI, Funder JW: Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev, 1988, 9, 159-179.
36. Texier PL, De Keyzer Y, Lacave R, Vieau D, Lenne F, Rojas-Miranda A, Verley JM et al.: Proopiomelanocortin gene expression in normal and tumoral human lung. J Clin Endocrin Metab, 1991, 73, 414-420.
37. Verma-Gandhu M, Verdu EF, Cohen-Lyons D, Collins SM: Lymphocyte-mediated regulation of beta-endorphin in the myenteric plexus. Am J Physiol Gastrointest Liver Physiol, 2007, 292, G344-348.
38. Wang L, Tiniakov RL, Yeates DB: Peripheral opioidergic regulation of the tracheobronchial mucociliary transport system. J Appl Physiol, 2003, 94, 2375-2383.
39. Wine J: Parasympathetic control of airway submucosal glands: central reflexes and the airway intrinsic nervous system. Auton Neurosci, 2007, 133, 35-54.
40. Yu Y, Wang X, Cui Y, Fan Y, Liu J, Wang R: Abnormal modulation of cholinergic neurotransmission by endomorphin 1 and endomorphin 2 in isolated bronchus of type 1 diabetic rats. Peptides, 2006, 27, 2770-2777.
41. Zagon IS, Rahn KA, McLaughlin PJ: Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells. Neuropeptides, 2007, 41, 441-452.